Blog

Cathy Eng: Beyond the headlines, The Real Impact of Early-Onset Cancers

Cathy Eng/X

Jun 3, 2025, 12:44

Cathy Eng: Beyond the headlines, The Real Impact of Early-Onset Cancers

Cathy Eng, Associate Director of Strategic Relations and Research Partners and Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center, shared a post on X:

“It was so wonderful to be able to participate in this ASCO session “Beyond the headlines: The Real Impact of Early-Onset Cancers”.Kimryn Rathmell, Katie Coleman, LeeAnne Bailey, Andrew Chang, NCI Cancer Trials, Mass General.”

Cathy Eng shared her involvement in an ASCO session focused on the real-world effects of early-onset cancers. The discussion featured multiple experts, highlighting diverse perspectives from institutions including NCI and Mass General.

More posts featuring Cathy Eng.

Andrew Chang ASCO25 cancer Cathy Eng fight against cancer gastrointestinal cancer Global fight against cancer Katie Coleman Kimryn Rathmell LeeAnne Bailey Mass General NCI Cancer Trials OncoDaily Oncology Vanderbilt-Ingram Cancer Center

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Kevin Conroy: Oncodetect is Now Covered by Medicare in Stage IV Colorectal Cancer